https://www.selleckchem.com/pr....oducts/stat3-in-1.ht
This paper reviews the different US technologies used for predicting NAC response in BC patients based on the previous literature. Endometrial cancer (EC) is the most common gynaecologic malignancy in the developed world, and incidence is increasing in premenopausal women. The levonorgestrel intrauterine system (LNG-IUS) is gaining traction as an alternative treatment for hyperplasia and early-stage EC for women who are unable to undergo surgery. Thirty to 60% of the women do not respond to this treatment, making the unknown mechanis
Like
Comment
Share
